{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T22:41:02Z","timestamp":1778193662617,"version":"3.51.4"},"reference-count":30,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2012,7,26]],"date-time":"2012-07-26T00:00:00Z","timestamp":1343260800000},"content-version":"vor","delay-in-days":8152,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brit J Clinical Pharma"],"published-print":{"date-parts":[[1990,4]]},"abstract":"<jats:p>1. The aim of the study was to compare the efficacy and the tolerability of treatment with atenolol (50\u2010100 mg once daily), nitrendipine (20\u201040 mg once daily) and their combination (atenolol 50 mg + nitrendipine 20 mg) once daily in patients with mild to moderate essential hypertension. 2. The study was a randomised, double\u2010blind, placebo controlled parallel groups design: blood pressures were measured at \u2018trough\u2019 effect (i.e. 24 h after dosing) to assess the adequacy of once\u2010daily treatment. 3. Mean blood pressures (mm Hg) recorded on four occasions over 12 weeks of treatment were significantly lower both with atenolol (155\/97 sitting: 155\/104 standing) and with the combination of atenolol plus nitrendipine (153\/96 sitting: 152\/104 standing) than with placebo (169\/108 sitting: 169\/114 standing). Nitrendipine alone had no significant effect on blood pressure 24 h after dosing (165\/104 sitting: 165\/110 standing). 4. Withdrawals due to adverse effects were more common during treatment with nitrendipine: 7\/32 of the patients experienced adverse effects attributable to intense systemic vasodilatation (e.g., flushing, erythema, headache). 2\/37 patients taking atenolol were withdrawn: one because he developed a psoriatic rash and the other because of impaired peripheral circulation. Of the 35 patients taking combination treatment, two were withdrawn: one developed headaches and dyspnoea, and the other asthma. 5. The results suggest that once daily dosing with nitrendipine does not control blood pressure throughout the 24 h period in the majority of patients, and is associated with a considerable burden of adverse effects. Combination treatment was better tolerated but appeared to offer no advantages over atenolol alone in terms either of blood pressure control or adverse effects.<\/jats:p>","DOI":"10.1111\/j.1365-2125.1990.tb03664.x","type":"journal-article","created":{"date-parts":[[2012,7,27]],"date-time":"2012-07-27T00:20:32Z","timestamp":1343348432000},"page":"455-463","source":"Crossref","is-referenced-by-count":6,"title":["Comparison of once daily atenolol, nitrendipine and their combination in mild to moderate essential hypertension."],"prefix":"10.1111","volume":"29","author":[{"given":"D","family":"Maclean","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ET","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N","family":"Irvine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JS","family":"McLay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"McEwen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"RR","family":"Coulson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ND","family":"Slater","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"TJ","family":"Fitzsimons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DG","family":"McDevitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2012,7,26]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(86)70265-X"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.298.6675.694"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-198300252-00010"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(86)90740-X"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.6026.7"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-198733020-00003"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1989.tb05387.x"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.2169\/naika.70.580"},{"issue":"7","key":"e_1_2_1_10_1","first-page":"S1053","article-title":"Efficacy and safety of nitrendipine in patients with severe hypertension: a multiclinic study","author":"Jain A. K.","year":"1984","journal-title":"J. cardiovasc. Pharmac"},{"key":"e_1_2_1_11_1","first-page":"147","article-title":"Amiloride compared with nitrendipine in treatment of essential hypertension","volume":"2","author":"Katzman P. L.","year":"1988","journal-title":"J. human Hypertension"},{"key":"e_1_2_1_12_1","first-page":"191","article-title":"Efficacy of once daily nitrendipine in essential hypertension\u2014a study using ambulatory blood pressure monitoring","volume":"2","author":"Lazarus J. H.","year":"1988","journal-title":"J. human Hypertension"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00561384"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-198325020-00006"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-198308000-00008"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1988.tb03325.x"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.291.6488.97"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.296.6636.1565"},{"key":"e_1_2_1_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(84)80079-0"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.287.6387.257"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.296.6620.468"},{"key":"e_1_2_1_22_1","first-page":"641P","article-title":"A comparison of compliance with tablets prescribed once, twice or three times daily","volume":"25","author":"Pullar T.","year":"1988","journal-title":"Br. J. clin. Pharmac."},{"issue":"2","key":"e_1_2_1_23_1","first-page":"18","article-title":"Pharmacokinetics and metabolism of nifedipine","volume":"5","author":"Raemsch K. D.","year":"1983","journal-title":"Hypertension"},{"key":"e_1_2_1_24_1","first-page":"1","article-title":"Managing mild hypertension","volume":"27","author":"Ramsay L. E.","year":"1987","journal-title":"Prescribers J."},{"key":"e_1_2_1_25_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.295.6599.637"},{"key":"e_1_2_1_26_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-198530030-00002"},{"key":"e_1_2_1_27_1","first-page":"631P","article-title":"Effects of pindolol and xamoterol on plasma creatine kinase in healthy subjects","volume":"26","author":"Tomlinson B.","year":"1988","journal-title":"Br. J. clin. Pharmac."},{"issue":"7","key":"e_1_2_1_28_1","first-page":"S1090","article-title":"Clinical experience with long\u2010term nitrendipine treatment in essential hypertension","volume":"6","author":"Tourkantonis A.","year":"1984","journal-title":"J. cardiovasc. Pharmac."},{"key":"e_1_2_1_29_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1985.135"},{"key":"e_1_2_1_30_1","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1001\/jama.1988.03720130040027","article-title":"Primary prevention with metoprolol in patients with hypertension","volume":"759","author":"Wickstrand J.","year":"1988","journal-title":"J. Am. med. Ass."},{"key":"e_1_2_1_31_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-198606000-00021"}],"container-title":["British Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2125.1990.tb03664.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-2125.1990.tb03664.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,22]],"date-time":"2023-10-22T10:18:34Z","timestamp":1697969914000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2125.1990.tb03664.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,4]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1990,4]]}},"alternative-id":["10.1111\/j.1365-2125.1990.tb03664.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-2125.1990.tb03664.x","archive":["Portico"],"relation":{},"ISSN":["0306-5251","1365-2125"],"issn-type":[{"value":"0306-5251","type":"print"},{"value":"1365-2125","type":"electronic"}],"subject":[],"published":{"date-parts":[[1990,4]]}}}